Skip to content

SNDX - Syndax Pharmaceuticals Inc - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchS

Syndax Pharmaceuticals Inc

SNDX · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

S

SNDXSyndax Pharmaceuticals Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $25.59
52-wk low: $12.99
Prev close: $21.22
Mkt cap: $1.78B
Beta: 0.37
P/S: 7.0x

Smart money

8 funds hold a position and insiders have been net selling.

Real smart money

Funds holding this stock

8 holders

Combined position$580.8M

P7
Point72
Steven Cohen · Q1 2026 13F
$46.4M
position
MI
Millennium

Earnings

Reported Aug 3, 2026

Earnings came in 22.2% below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -87.5%
Market cap: $1.8B

Valuation

P/S7.05
P/B116.86

Quality

Operating margin-54.9%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: SNDX
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $1.78B
Beta: 0.37

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

116.9x

Profit margin

-87.5%

Op margin

-54.9%

ROE

-255.9%

Israel Englander · Q2 2026 13F

$44.9M

position

TS

Two Sigma

Q2 2026 13F

$34.5M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for SNDX

No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.55-22.2%

-$0.45 expected

Next report

What the street expects next

-255.9%

ROA-18.7%

Growth

Beta0.37